Oncology
Partner With Us
Advertisement
Clinical Guidelines From the Journals

The Role of Locoregional and Systemic Therapies in the Management of Colorectal Liver Metastases

In this video, Dr. Castellanos explains the role of surgical resection in the management of liver-confined metastatic colorectal cancer and using hepatic artery infusion pump (HAIP) chemotherapy for treating resectable and unresectable colorectal liver metastases.

Fox Chase Cancer Center
The Role of Locoregional and Systemic Therapies in the Management of Colorectal Liver Metastases Somewhere around 50 percent of patients with colon cancer spread to the liver cannot be treated surgically. The hepatic artery pump is a highly effective way to get them to a point where they can undergo surgery,” says Jason Castellanos, MD, assistant professor, Fox Chase Department of Surgical Oncology. In this video, Dr. Castellanos explains the role of surgical resection in the management of liver-confined metastatic colorectal cancer and using hepatic artery infusion pump (HAIP) chemotherapy for treating resectable and unresectable colorectal liver metastases. Topics include: Epidemiology of Colorectal Liver Metastases (CRLM) Role of Liver Resection for CRLM HAIP for Unresectable CRLM HAIP for Adjuvant Therapy